Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Thrombosis-Related Factors FV and F13A1 Mutations in Uterine Myomas

Marzieh Ahmadi 1 , Mahboobeh Nasiri 1 , * and Ahmad Ebrahimi 2
Authors Information
1 Department of Biology, Islamic Azad University, Arsanjan Branch, Arsanjan, IR Iran
2 Cellular and Molecular Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: October 2016, 18 (10); e4836
  • Published Online: September 28, 2016
  • Article Type: Research Article
  • Received: November 28, 2015
  • Revised: December 26, 2015
  • Accepted: September 24, 2016
  • DOI: 10.17795/zjrms-4836

To Cite: Ahmadi M, Nasiri M, Ebrahimi A. Thrombosis-Related Factors FV and F13A1 Mutations in Uterine Myomas, Zahedan J Res Med Sci. 2016 ; 18(10):e4836. doi: 10.17795/zjrms-4836.

Copyright © 2016, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Neiger R, Sonek JD, Croom CS, Ventolini G. Pregnancy-related changes in the size of uterine leiomyomas. J Reprod Med. 2006; 51(9): 671-4[PubMed]
  • 2. Ruf W. Tissue factor and cancer. Thromb Res. 2012; 130 Suppl 1-7[DOI][PubMed]
  • 3. Trikha M, Nakada MT. Platelets and cancer: implications for antiangiogenic therapy. Semin Thromb Hemost. 2002; 28(1): 39-44[DOI][PubMed]
  • 4. Vairaktaris E, Yapijakis C, Wiltfang J, Ries J, Vylliotis A, Derka S, et al. Are factor V and prothrombin mutations associated with increased risk of oral cancer? Anticancer Res. 2005; 25(3c): 2561-5[PubMed]
  • 5. Palla A, Celi A, Marconi L, Pistelli F, Tavanti L, Desideri M, et al. Venous Thromboembolism in Cancer: Frequently Asked Questions When Guidelines are Inconclusive. Cancer Invest. 2015; 33(4): 142-51[DOI][PubMed]
  • 6. Kitajima T, Hatano E, Mitsunori Y, Taura K, Fujimoto Y, Mizumoto M, et al. Complete pathological response induced by sorafenib for advanced hepatocellular carcinoma with multiple lung metastases and venous tumor thrombosis allowing for curative resection. Clin J Gastroenterol. 2015; 8(5): 300-5[DOI][PubMed]
  • 7. Haynes MC, Lu BY, Winkel AF. Ovarian vein thrombophlebitis related to large uterine myoma. Obstet Gynecol. 2014; 123(2 Pt 2 Suppl 2): 450-3[DOI][PubMed]
  • 8. Wu CJ, Huang KH, Liu JY. Ovarian vein thrombosis associated with compression by a uterine myoma. Eur J Obstet Gynecol Reprod Biol. 2011; 159(2): 485-7[DOI][PubMed]
  • 9. Board PG, Chapple R, Coggan M. Haplotypes of the coagulation factor XIII A subunit locus in normal and deficient subjects. Am J Hum Genet. 1988; 42(5): 712-7[PubMed]
  • 10. Coggan M, Baker R, Miloszewski K, Woodfield G, Board P. Mutations causing coagulation factor XIII subunit A deficiency: characterization of the mutant proteins after expression in yeast. Blood. 1995; 85(9): 2455-60[PubMed]
  • 11. Morelli VM, De Visser MC, Vos HL, Bertina RM, Rosendaal FR. ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden. J Thromb Haemost. 2005; 3(1): 183-5[DOI][PubMed]
  • 12. Ichinose A, Davie EW. Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor. Proc Natl Acad Sci U S A. 1988; 85(16): 5829-33[PubMed]
  • 13. Ariens RA, Philippou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood. 2000; 96(3): 988-95[PubMed]
  • 14. Nadir Y, Brenner B, Gingis-Velitski S, Levy-Adam F, Ilan N, Zcharia E, et al. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells. Thromb Haemost. 2008; 99(1): 133-41[PubMed]
  • 15. Van Hylckama Vlieg A, Komanasin N, Ariens RA, Poort SR, Grant PJ, Bertina RM, et al. Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis. Br J Haematol. 2002; 119(1): 169-75[PubMed]
  • 16. Cripe LD, Moore KD, Kane WH. Structure of the gene for human coagulation factor V. Biochemistry. 1992; 31(15): 3777-85[PubMed]
  • 17. Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood. 2005; 105(1): 178-85[DOI][PubMed]
  • 18. Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril. 2007; 87(4): 725-36[DOI][PubMed]
  • 19. Longmire JL, Albright KL, Lewis AK, Meincke LJ, Hildebrand CE. A rapid and simple method for the isolation of high molecular weight cellular and chromosome-specific DNA in solution without the use of organic solvents. Nucleic Acids Res. 1987; 15(2): 859[PubMed]
  • 20. Vairaktaris E, Vassiliou S, Yapijakis C, Spyridonidou S, Vylliotis A, Derka S, et al. Increased risk for oral cancer is associated with coagulation factor XIII but not with factor XII. Oncol Rep. 2007; 18(6): 1537-43[PubMed]
  • 21. Boccaccio C, Sabatino G, Medico E, Girolami F, Follenzi A, Reato G, et al. The MET oncogene drives a genetic programme linking cancer to haemostasis. Nature. 2005; 434(7031): 396-400[DOI][PubMed]
  • 22. Hodge JC, Morton CC. Genetic heterogeneity among uterine leiomyomata: insights into malignant progression. Hum Mol Genet. 2007; 16 Spec No 1-13[DOI][PubMed]
  • 23. Dehraisi M, Sadat S, Sadat SM, Davari Tanha F, Aghasadeghi M, Bahramali G, et al. The effect of glutathione S-transferase gene polymorphisms on susceptibility to uterine myoma. Tehran Univ Med J. 2015; 72(10): 667-73
  • 24. Taghizade Mortezaee F, Hashemzadeh Chaleshtori M, Kheiri S, Farrokhi E, Shariati L, Tabatabaiefar MA. Interleukin-1b gene polymorphisms in iranian patients with uterine fibroid, A case- control study. Biosci Biotech Res Asia. 2015; 12(1): 341-5
  • 25. Salimi S, Mohammadoo-Khorasani M, Namazi L, Naghavi A, Yaghmaei M. Association between interleukin 4 gene seventy-base-pair variable number of tandem repeats polymorphism and uterine leiomyoma. Gene, Cell and Tissue. 2014; 1(2)
  • 26. Wang F, Chen J, Wang L, Ma Y, Mayinuer N. CYP1A1 genetic polymorphisms and uterine leiomyoma risk: a meta-analysis. Int J Clin Exp Med. 2015; 8(3): 3590-4[PubMed]
  • 27. Mu X, Du X, Yao K, Zhao J, Bian C, Wang Q, et al. Association between HSD17B1 rs605059 polymorphisms and the risk of uterine diseases: a systemic review and meta-analysis. Int J Clin Exp Pathol. 2015; 8(6): 6012-8[PubMed]
  • 28. Falanga A, Marchetti M, Vignoli A. Coagulation and cancer: biological and clinical aspects. J Thromb Haemost. 2013; 11(2): 223-33[DOI][PubMed]
  • 29. Fernandes F, Dinardo C, Terra‐Filho M. Uterine myoma as a cause of iliac vein thrombosis and pulmonary embolism: common disease, rare complication. Respirology Case Reports. 2014; 2(4): 132-4
  • 30. Hoh JK, Lee WM, Lee HJ, Hwang JH. Misdiagnosis of a large uterine vein thrombosis as a uterine myoma prior to hysterectomy: a case report. Ann Acad Med Singapore. 2013; 42(2): 88-90[PubMed]
  • 31. van der Meijden PE, Heemskerk JW. Polyphosphates: a link between platelet activation, intrinsic coagulation and inflammation? Expert Rev Hematol. 2010; 3(3): 269-72[DOI][PubMed]
  • 32. van Wijk R, Nieuwenhuis K, van den Berg M, Huizinga EG, van der Meijden BB, Kraaijenhagen RJ, et al. Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency. Blood. 2001; 98(2): 358-67[PubMed]
  • 33. Franco RF, Reitsma PH, Lourenco D, Maffei FH, Morelli V, Tavella MH, et al. Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis. Thromb Haemost. 1999; 81(5): 676-9[PubMed]
  • 34. Corapcioglu F, Basar EZ, Demirel A, Inan N, Babaoglu K, Karakurt H, et al. Granulomatous reaction in mediastinal B-cell non-Hodgkin lymphoma and intracardiac thrombosis. Pediatr Hematol Oncol. 2008; 25(3): 217-26[DOI][PubMed]
  • 35. Vossen CY, Hoffmeister M, Chang-Claude JC, Rosendaal FR, Brenner H. Clotting factor gene polymorphisms and colorectal cancer risk. J Clin Oncol. 2011; 29(13): 1722-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments